Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral and Gastric H. pylori Eradication Study
NCT01863823Phase 2Completed
- Sponsor
- Ameritek
- Start
- Aug 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of amoxicillin, tetracycline and cetylpyridinium chloride + zinc lactate + sodium fluoride in Helicobacter pylori infection, sponsored by Ameritek. Primary endpoint: Success Rate of H. pylori Eradication at 12 months. Started Aug 2011; status: completed.
02
Drugs
amoxicillintetracyclinecetylpyridinium chloride + zinc lactate + sodium fluoride
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01863823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863823.